131 related articles for article (PubMed ID: 37232453)
1. Machine learning-based drug design for identification of thymidylate kinase inhibitors as a potential anti-Mycobacterium tuberculosis.
Shahab M; Danial M; Duan X; Khan T; Liang C; Gao H; Chen M; Wang D; Zheng G
J Biomol Struct Dyn; 2024 May; 42(8):3874-3886. PubMed ID: 37232453
[TBL] [Abstract][Full Text] [Related]
2. Machine Learning-based Virtual Screening for STAT3 Anticancer Drug Target.
Wadood A; Ajmal A; Junaid M; Rehman AU; Uddin R; Azam SS; Khan AZ; Ali A
Curr Pharm Des; 2022; 28(36):3023-3032. PubMed ID: 35909285
[TBL] [Abstract][Full Text] [Related]
3. In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against
Venugopala KN; Tratrat C; Pillay M; Chandrashekharappa S; Al-Attraqchi OHA; Aldhubiab BE; Attimarad M; Alwassil OI; Nair AB; Sreeharsha N; Venugopala R; Morsy MA; Haroun M; Kumalo HM; Odhav B; Mlisana K
Drug Des Devel Ther; 2020; 14():1027-1039. PubMed ID: 32214795
[TBL] [Abstract][Full Text] [Related]
4. Machine learning and molecular simulation-based protocols to identify novel potential inhibitors for reverse transcriptase against HIV infections.
Shahab M; Zheng G; Bin Jardan YA; Bourhia M
J Biomol Struct Dyn; 2024 Feb; ():1-14. PubMed ID: 38379294
[TBL] [Abstract][Full Text] [Related]
5. Elaboration of a proprietary thymidylate kinase inhibitor motif towards anti-tuberculosis agents.
Song L; Risseeuw MDP; Froeyen M; Karalic I; Goeman J; Cappoen D; Van der Eycken J; Cos P; Munier-Lehmann H; Van Calenbergh S
Bioorg Med Chem; 2016 Nov; 24(21):5172-5182. PubMed ID: 27614917
[TBL] [Abstract][Full Text] [Related]
6. A new family of inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.
Gasse C; Huteau V; Douguet D; Munier-Lehmann H; Pochet S
Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1057-61. PubMed ID: 18058536
[No Abstract] [Full Text] [Related]
7. Identification of potential non-nucleoside MraY inhibitors for tuberculosis chemotherapy using structure-based virtual screening.
Pandey P; Chatterjee S; Berida T; Doerksen RJ; Roy S
J Biomol Struct Dyn; 2022 Jul; 40(11):4832-4849. PubMed ID: 33353500
[TBL] [Abstract][Full Text] [Related]
8. Structure-aided design of inhibitors of Mycobacterium tuberculosis thymidylate kinase.
Van Calenbergh S
Verh K Acad Geneeskd Belg; 2006; 68(4):223-48. PubMed ID: 17214439
[TBL] [Abstract][Full Text] [Related]
9. Screening of Antitubercular Compound Library Identifies Inhibitors of Mur Enzymes in
Eniyan K; Rani J; Ramachandran S; Bhat R; Khan IA; Bajpai U
SLAS Discov; 2020 Jan; 25(1):70-78. PubMed ID: 31597510
[TBL] [Abstract][Full Text] [Related]
10. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure activity relationships of cyanopyridone based anti-tuberculosis agents.
Jian Y; Hulpia F; Risseeuw MDP; Forbes HE; Munier-Lehmann H; Caljon G; Boshoff HIM; Van Calenbergh S
Eur J Med Chem; 2020 Sep; 201():112450. PubMed ID: 32623208
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of consensus machine learning-based models for the prediction of novel small molecules as potential anti-tubercular agents.
Wani MA; Roy KK
Mol Divers; 2022 Jun; 26(3):1345-1356. PubMed ID: 34110578
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 5'-modified thymidines and 5-hydroxymethyl-2'-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors.
Toti KS; Verbeke F; Risseeuw MD; Frecer V; Munier-Lehmann H; Van Calenbergh S
Bioorg Med Chem; 2013 Jan; 21(1):257-68. PubMed ID: 23199481
[TBL] [Abstract][Full Text] [Related]
14. 1-(Piperidin-3-yl)thymine amides as inhibitors of
Jian Y; Risseeuw MDP; Froeyen M; Song L; Cappoen D; Cos P; Munier-Lehmann H; van Calenbergh S
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1730-1739. PubMed ID: 31822127
[TBL] [Abstract][Full Text] [Related]
15. Virtual screening to identify novel potential inhibitors for Glutamine synthetase of
Kumari M; Subbarao N
J Biomol Struct Dyn; 2020 Oct; 38(17):5062-5080. PubMed ID: 31755360
[TBL] [Abstract][Full Text] [Related]
16. Protein kinases as antituberculosis targets: The case of thymidylate kinases.
Sukumar S; Krishman A; Khan MKA
Front Biosci (Landmark Ed); 2020 Mar; 25(9):1636-1654. PubMed ID: 32114448
[TBL] [Abstract][Full Text] [Related]
17. In Silico Prediction of New Inhibitors for Kirsten Rat Sarcoma G12D Cancer Drug Target Using Machine Learning-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulation Approaches.
Ajmal A; Danial M; Zulfat M; Numan M; Zakir S; Hayat C; Alabbosh KF; Zaki MEA; Ali A; Wei D
Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794122
[TBL] [Abstract][Full Text] [Related]
18. Exploring acyclic nucleoside analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
Familiar O; Munier-Lehmann H; Negri A; Gago F; Douguet D; Rigouts L; Hernández AI; Camarasa MJ; Pérez-Pérez MJ
ChemMedChem; 2008 Jul; 3(7):1083-93. PubMed ID: 18418833
[TBL] [Abstract][Full Text] [Related]
19. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
20. Machine learning and docking models for Mycobacterium tuberculosis topoisomerase I.
Ekins S; Godbole AA; Kéri G; Orfi L; Pato J; Bhat RS; Verma R; Bradley EK; Nagaraja V
Tuberculosis (Edinb); 2017 Mar; 103():52-60. PubMed ID: 28237034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]